Results 181 to 190 of about 1,399,338 (302)

Spontaneous Splenic Artery Rupture in a Young Adult Without Aneurysmal Disease or Known Risk Factors. [PDF]

Cureus
Toman JW, Sauder M, Gruber B.
europepmc   +1 more source

Clinical neuroanatomy teaching at Peking University Health Science Center: Evolution, current practice, and future direction

Anatomical Sciences Education, EarlyView.
Abstract Neuroanatomy has been considered one of the most challenging subjects in medical education, often leading to “neurophobia” and discouraging students from pursuing neurological specialties. At PKUHSC, the curriculum has evolved from a traditional, discipline‐based model to a technology‐enhanced, integrated “Nervous System” module for ...
Xuan Fang, Man Li, Xiaodan Hu, Chang Su, Shan Ye, Xianzhong Shi, Xiaomei Yang, Changman Zhou, Weiguang Zhang, Chunhua Chen   +9 more
wiley   +1 more source

Successful treatment of noninfectious hemorrhagic cystitis with intravesical hyaluronic acid in a 5-year-old boy: a case report. [PDF]

Oxf Med Case Reports
Zvizdic Z, Jonuzi A, Hakulija M, Vranic S.   +3 more
europepmc   +1 more source

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque‐Pereira, Christine Leopold, Patrick C. Souverein, Aukje K. Mantel‐Teeuwisse, Marie L. De Bruin   +6 more
wiley   +1 more source

Dermatomal Microcycstic Lymphatic Malformation: A Case Report of an Unusual Presentation. [PDF]

Clin Cosmet Investig Dermatol
Alzhrani G, Alhawsawi W, Alzaidi R, Alghamdi FA, Alghamdi B, Makhdoum S.   +5 more
europepmc   +1 more source

Applying machine learning to pharmacovigilance data: A proof‐of‐concept study

British Journal of Clinical Pharmacology, EarlyView.
Aim Machine learning (ML) applications in pharmacovigilance remain limited and underexplored. Using data from the French National pharmacovigilance database (FNPV), this proof‐of‐concept study aimed to assess the feasibility of using a ML algorithm—eXtreme Gradient Boosting (XGBoost)—combined with SHapley Additive exPlanations (SHAP) analysis, to ...
Romain Barus, Pauline Schiro, Jean‐Luc Faillie, Romane Freppel, Johana Béné, Claire de Canecaude, François Montastruc   +6 more
wiley   +1 more source

Anesthesia Management of Awake Craniotomy for Excision of a Supratentorial Hemorrhagic Brain Tumor Affecting Speech and Memory. [PDF]

Am J Case Rep
Hugues A, Rechter T, Poblete A, Thornton I.   +3 more
europepmc   +1 more source

Long‐acting cabotegravir and rilpivirine in people with HIV receiving chronic anticoagulation: A real‐world case series

British Journal of Clinical Pharmacology, EarlyView.
Background Long‐acting intramuscular cabotegravir plus rilpivirine (LA‐CAB + RPV) is an effective maintenance antiretroviral regimen for virologically suppressed people with HIV. However, its use in individuals receiving chronic anticoagulation is limited by concerns regarding intramuscular bleeding risk, and real‐world data are scarce.
Montserrat Laguno, Berta Torres, Maria Martínez‐Rebollar, Paula Arreba, Octavi Roman, Roger LLobet, Leire Berrocal, Alberto Foncillas, Júlia Calvo, Abiu Sempere, Ivan Chivite, Elisa de Lazzari, Josep Mallolas, Ana González‐Cordón   +13 more
wiley   +1 more source

Spontaneous hemorrhage of cavernous malformation in the region of the cochlear nucleus: A case report. [PDF]

Radiol Case Rep
Almaazmi R, Ahmad A, Schlemmer K, Dogar MA.   +3 more
europepmc   +1 more source

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

British Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou, Alexander T. Cohen, Lucy Vernon, Victoria Collings, Ubonphan Chaichana, Natasha Moore, Hamda Jibril, Li Wei, Nicola Kumar, Karen A. Breen, Andrew J. Doyle   +10 more
wiley   +1 more source